Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseases HS235 offers potential to treat pulmonary ...
The AHA and ACC issued a guideline on a clinical classification system to define the severity of an acute PE and assist in developing treatment strategies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results